Yuxin Zhao

No ORCID on file · 5 papers in corpus
observational 2026
·doi:10.1186/s12905-026-04962-6

Abstract Background The levonorgestrel-releasing intrauterine system (LNG-IUS) is effective for adenomyosis, yet expulsion frequently limits its clinical application. This study aimed to compare clinical outcomes of three hysteroscopic LNG-…

lab-animal 2026
Advanced science (Weinheim, Baden-Wurttemberg, Germany) ·doi:10.1002/advs.75442

Endometriosis (EMs) features ectopic implantation of endometrial stromal cells (EESCs) and strong anoikis resistance, yet how inflammatory signals reprogram mitochondrial function remains unclear. Here, neutrophil extracellular traps (NETs)…

lab-animal 2026
Cellular signalling ·doi:10.1016/j.cellsig.2026.112620

Long non-coding RNA Urothelial carcinoma-associated 1 (UCA1) is a pivotal regulator in the progression of endometriosis (EMs), yet its mechanistic role remains elusive. This study identified UCA1 as a factor promoting glycolysis through bio…

observational 2025
Journal of biomedical research ·doi:10.7555/jbr.39.20250205

This study investigated differences in reproductive outcomes and vaginal microbiota profiles between two endometrial preparation protocols-letrozole (LE) combined with human menopausal gonadotropin (HMG) and hormone replacement therapy (HRT…

review 2025
Journal of ovarian research ·doi:10.1186/s13048-025-01864-3

Ovarian cancer remains the most lethal malignancy of the female reproductive tract. Because early-stage disease is almost silent, roughly 70% of patients present with advanced, disseminated tumors. The current standard-maximal cytoreductive…